MedPath

Medicines360

Medicines360 logo
🇺🇸United States
Ownership
Private
Established
2009-01-01
Employees
11
Market Cap
-
Website
http://www.medicines360.org

Clinical Trials

2

Active:0
Completed:1

Trial Phases

1 Phases

Phase 3:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 3
2 (100.0%)

Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding

Phase 3
Completed
Conditions
Menorrhagia
First Posted Date
2018-08-22
Last Posted Date
2024-05-14
Lead Sponsor
Medicines360
Target Recruit Count
105
Registration Number
NCT03642210
Locations
🇺🇸

MomDoc Women's Health Research, Scottsdale, Arizona, United States

🇺🇸

OB/GYN Research, University of California, Davis Health, Sacramento, California, United States

🇺🇸

Wr-McCr, Llc, San Diego, California, United States

and more 26 locations

A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception

Phase 3
Terminated
Conditions
Contraception
Interventions
First Posted Date
2009-10-15
Last Posted Date
2024-08-14
Lead Sponsor
Medicines360
Target Recruit Count
1910
Registration Number
NCT00995150
Locations
🇺🇸

Magee Women's Hospital, University of Pittsburgh, Pittsburgh, Pennsylvania, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.